HSV1 ICP4 抗体
-
- 抗原 See all HSV1 ICP4 products
- HSV1 ICP4 (Herpes Simplex Virus Type 1 ICP4 (HSV1 ICP4))
-
适用
- Herpes Simplex Virus (HSV)
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This HSV1 ICP4 antibody is un-conjugated
-
应用范围
- ELISA, Western Blotting (WB), Immunofluorescence (IF)
- 纯化方法
- Affinity Purified
- 纯度
- > 95 % IgG by SDS-PAGE
- 克隆位点
- 10F1
- 亚型
- IgG1 kappa
-
-
- 应用备注
- Western Blotting: > 1:600. Immunofluorescence: 1+ at 1:25.600. ELISA: 0.100 at 1:26.600
- 限制
- 仅限研究用
-
- 浓度
- 1.0 mg/ml
- 缓冲液
- Phosphate Buffered Saline pH 7.4 (no azide)
- 储存液
- Azide free
-
-
Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment." in: PLoS pathogens, Vol. 12, Issue 9, pp. e1005834, (2016) (PubMed).
: "Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2." in: Journal of virology, Vol. 85, Issue 17, pp. 8738-51, (2011) (PubMed).
: "Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis." in: Journal of virology, Vol. 83, Issue 18, pp. 9131-9, (2009) (PubMed).
: "PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B." in: Cell, Vol. 132, Issue 6, pp. 935-44, (2008) (PubMed).
: "
-
Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment." in: PLoS pathogens, Vol. 12, Issue 9, pp. e1005834, (2016) (PubMed).
-
- 抗原
- HSV1 ICP4 (Herpes Simplex Virus Type 1 ICP4 (HSV1 ICP4))
- 别名
- HSV-1 ICP4 Immediate Early Protein (HSV-1 ICP4) (HSV1 ICP4 产品)
- 物质类
- Viral Protein
- 背景
- Synonyms: ICP4, IE175
-